Reply by Authors.

Veerman, Hans; Houwink, Aletta P I; Schutte, Peter F E; Nieuwenhuijzen, Jakko A; Roeleveld, Ton A; Wit, Esther; Mazel, Jan Willem; van der Sluis, Tim M; Vis, André N; van Leeuwen, Pim J; van der Poel, Henk G

Reply by Authors.

Veerman, Hans; Houwink, Aletta P I; Schutte, Peter F E; Nieuwenhuijzen, Jakko A; Roeleveld, Ton A; Wit, Esther; Mazel, Jan Willem; van der Sluis, Tim M; Vis, André N; van Leeuwen, Pim J; van der Poel, Henk G.

Afiliación

Veerman H; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Houwink API; Department of Urology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Schutte PFE; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
Nieuwenhuijzen JA; Department of Anesthesiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Roeleveld TA; Department of Anesthesiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Wit E; Department of Urology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Mazel JW; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
van der Sluis TM; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
Vis AN; Department of Urology, Noord-West Ziekenhuis, Den Helder, the Netherlands.
van Leeuwen PJ; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
van der Poel HG; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.

J Urol ; 205(6): 1680, 2021 06.

Article en En | MEDLINE | ID: mdl-33734854

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Urol Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos